Technical Analysis for TARO - Taro Pharmaceutical Industries

Grade Last Price % Change Price Change
B 42.30 0.24% 0.10
TARO closed up 0.24 percent on Friday, May 17, 2024, on 66 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
Earnings due: May 21
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Flat

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Three Weeks Tight Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Gapped Up Strength 0.00%
Lower Bollinger Band Touch Weakness 0.00%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taro Pharmaceutical Industries Description

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, together with its subsidiaries, engages in the research, development, production, and marketing of pharmaceutical products primarily in the United States, Canada, and Israel. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas comprising topical creams and ointments, liquids, capsules, and tablets principally in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. Taro Pharmaceutical Industries Ltd. sells and distributes its products to drug wholesalers and store chains, generic drug distributors, mass merchandisers, food and retail chains, and managed care organizations. The company was founded in 1959 and is based in Haifa Bay, Israel.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Sciences Medication Pharmaceutical Products Pharmacology Retail Chain Store Chains Pharmaceutical Sciences Managed Care Active Pharmaceutical Ingredients Pharmaceutical Industries Ointments Topical Medication Drug Wholesalers Generic Drug Counter Pharmaceutical Products Patheon Perrigo Science And Technology In Israel Science Based Pharmaceutical

Is TARO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 45.76
52 Week Low 28.25
Average Volume 26,764
200-Day Moving Average 39.60
50-Day Moving Average 42.23
20-Day Moving Average 42.36
10-Day Moving Average 42.33
Average True Range 0.25
RSI (14) 50.25
ADX 14.27
+DI 18.35
-DI 12.41
Chandelier Exit (Long, 3 ATRs) 41.94
Chandelier Exit (Short, 3 ATRs) 42.82
Upper Bollinger Bands 42.57
Lower Bollinger Band 42.15
Percent B (%b) 0.36
BandWidth 0.99
MACD Line 0.02
MACD Signal Line 0.04
MACD Histogram -0.0239
Fundamentals Value
Market Cap 1.59 Billion
Num Shares 37.6 Million
EPS 1.22
Price-to-Earnings (P/E) Ratio 34.67
Price-to-Sales 2.62
Price-to-Book 0.89
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.64
Resistance 3 (R3) 42.62 42.49 42.58
Resistance 2 (R2) 42.49 42.41 42.50 42.56
Resistance 1 (R1) 42.40 42.35 42.33 42.41 42.54
Pivot Point 42.27 42.27 42.24 42.28 42.27
Support 1 (S1) 42.17 42.18 42.11 42.19 42.06
Support 2 (S2) 42.04 42.13 42.05 42.04
Support 3 (S3) 41.95 42.04 42.02
Support 4 (S4) 41.96